For the underlying pharmacology and trial efficacy that justifies any spend on these drugs, see (Jastreboff et al., 2022) for tirzepatide SURMOUNT-1 and (Wilding et al., 2021) for semaglutide STEP-1
Keep it refrigerated at 28C, protected from light, and within the window printed on its Certificate of Analysis
Wed advise discarding it
Clinical trial data show that gastrointestinal adverse effectsincluding nausea, vomiting, diarrhea, and abdominal discomfortoccur in 20-50% of patients initiating GLP-1 therapy, with rates varying by specific agent and dose
Aproximadamente 1 de cada 4 adultos mayores que tomaban tirzepatida experiment nuseas, alrededor de 1 de cada 10 dijo haber vomitado y alrededor de 1 de cada 5 report diarrea o estreimiento
La diabetes es una condicin crnica caracterizada por disfuncin progresiva de las clulas beta pancreticas y resistencia a la insulina, factores que no se resuelven completamente con el tratamiento farmacolgico